“…Mo(NAr)(CHR ′ )(Pyr) 2 R ′ = t-Bu or CMe 2 Ph [11] Mo(N-2,6-Br 2 -4-MeC 6 H 2 )(CH-t-Bu)(Pyr) 2 [11] Mo(NAd)(CHCMe 2 Ph)(Pyr) 2 [11] Mo(NAd)(CHCMe 2 Ph)(Pyr) 2 (PMe 3 )* [12] Mo(NR)(CHCMe 2 Ph)(Pyr) 2 (bipy) R = Ar*, Ad, Ar Me2 , Ar Cl , Ar iPr , Ar tBu , Ar Mes [55] Mo(NAr)(CHCMe 2 Ph)X 2 X = Me 4 Pyr*, i-Pr 2 Pyr*, Ph 2 Pyr*, Indolide* [12] Mo(NAr)(CH-t-Bu)(Ph 2 Pyr) 2 [12] Mo(NAr)(CHCMe 2 Ph)(indolide) 2 (THF) [12] Mo(NAr)(CHCMe 2 Ph)(R 2 Pz) 2 R 2 Pz = 3,5-diphenylpyrazolide* or 3,5-di-t-butylpyrazolide [32] (continued overleaf ) [38] W(NC 6 F 5 )(CH-t-Bu)(Pyr) 2 (DME) [18] 1.2 New Imido Ligands and Synthetic Approaches 5 [34] (continued overleaf ) *An X-ray structure was obtained for this compound bipy, 2,2-bipyridyl; DME, 1,2-dimethoxyethane; Mes, 2,4,6-trimethylphenyl; NAd, N-1-Admantyl; NAr, N-2,6-i-Pr 2 C 6 H 3 ; NAr R2 , N-2,6-R 2 C 6 H 3 ; NAr R , N-2-RC 6 H 4 ; NAr 3,5Me2 , N-3,5-Me 2 C 6 H 3 ; Biphen 2− , 3,3 ′ -di-t-Bu-5,5 ′ ,6,6 ′ -tetramethyl-1,1 ′ -biphenyl-2,2 ′ -diolate; OBr 2 Bitet, 3,3 ′ -dibromo-2 ′ -(tert-butyldimethylsilyloxy)-5,5 ′ ,6,6 ′ ,7,7 ′ ,8,8 ′ -octahydro-1,1 ′ -binaphthyl-2-olate; OHIPT, hexaisopropylterphenoxide = O-2,6-(2,4,6-i-Pr 3 C 6 H 2 ) 2 C 6 H 2 ; OHMT, hexamethylterphenoxide = O-2,6-Mes 2 C 6 H 2 ; ODFT, decafluoroterphenoxide = O-2,6-(C 6 F 5 ) 2 C 6 H 3 ; ODPP, 2,6-diphenylphenoxide; ODIPP, O-2,6-(i-Pr) 2 C 6 H 3 ; OR F6 , OCMe(CF 3 ) 2 ; OR F3 , OCMe 2 (CF 3 ); OBiphenTMS, O-3,3 ′ -di-tert-butyl-5,5 ′ ,6,6 ′ -tetramethyl-2 ′ -(trimethylsilyloxy)biphenyl-2-olate; OBINAP-TBS, O-2 ′ -(tert-butyldimethylsilyloxy)-1,1 ′ -binaphthyl-2-olate; ODPP R , 2,6-(2,5-R 2 pyrrolyl) 2 Phenoxide (R = i-Pr or Ph); Pyr, pyrrolide; MesPyr, 2-mesitylpyrrolide; CNPyr, 2-cyanopyrrolide; Me 4 Pyr, 2,3,4,5-tetramethylpyrrolide; R 2 Pyr, 2,5-R 2 pyrrolide; TBS, dimethyl-t-butylsilyl; Trip, 2,4,6-triisopropylphenyl.…”